**4. Conclusions**

According to the above discussed evidence and implications, the potential neurologic and cardiovascular consequences (**Figure 1**), coupled with the ensuing healthcare burden of COVID-19 necessitate a careful crafting of the clinical approach in the coming months and years. Both individuals who survived the infection and those who survived the pandemic without becoming infected with SARS-CoV2 (but were exposed to CMS) are at an appreciable risk of developing neurogenic and neuropsychiatric disturbances (**Figure 1**), and thus mental health checks for virtually all individuals on an ongoing basis are warranted. Furthermore, female gender may add another layer of risk for developing depression and CVD as a consequence of pandemic-associated CMS exposure. Studies conducted so far underscore the utility of echocardiography in revealing COVID-19-associated pericarditis, myocarditis and right heart dysfunction. Furthermore, resolution of inflammation should be at the forefront of treatment strategies, since prolonged inflammatory state is associated with poorer outcomes and LH COVID-19 symptomatology. Ultimately, clinical vigilance in monitoring individuals' mental and cardiovascular health will be of utmost importance in the post-pandemic years and research strategies aimed at mitigating the defunct mechanisms at the intersection of neurological and cardiovascular pathologies are merited.

*Chronic Mild Stress and COVID-19 Sequelae DOI: http://dx.doi.org/10.5772/intechopen.106578*
